• ALEXZA PHARMACEUTICALS INC Financial Overview

  • Income Statement: ALXA

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 0.00 1.03 M -1.03 M -∞ T%
    Gross Profit -4.02 M -2.65 M -1.37 M 34.04%
    Net Income Before Extra Items/Preferred Div -45.12 M -41.81 M -3.31 M 7.34%
    Operating Income -60.53 M -45.44 M -15.10 M 24.94%
  • Cash Flow: ALXA

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 70.09 M 94.93 M -24.84 M -35.44%
    Net Cash Flow - Investing 19.95 M 61.36 M -41.40 M -207.50%
    Net Cash Flow/Operating Activities -35.83 M -33.32 M -2.50 M 6.99%
  • Balance Sheet: ALXA

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 149.12 M 105.77 M 43.36 M 29.08%
    Total Liabilities 49.18 M 21.25 M 27.93 M 56.80%
    Shareholders Equity 75.99 M 49.77 M 26.22 M 34.50%
  • Key Ratios / Statistics: ALXA

    • Valuation

      Price/Earnings (TTM) -5.15
      Price/Sales (TTM) 216.99
      Price/Book (MRQ) 2.12
      Price/Cash Flow (TTM) -2.80
    • Profitability

      Gross Margin -257.68
      Operating Margin -4,419.75
      Profit Margin -4,066.73
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 7.47
      Current Ratio (MRQ) 5.85
      Long Term Debt-to-Equity (MRQ) 6.51
    • Management Effectiveness

      Return on Equity (TTM) -69.31
      Return on Assets (TTM) -37.40
      Return on Investments (TTM) -43.60